Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LUMISIGHT safely and effectively. See full prescribing information for LUMISIGHT. LUMISIGHT™ (pegulicianine) for injection, for intravenous useInitial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
LUMISIGHT is indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery.
- generic_name
- pegulicianine
- product_names
- Pegulicianine
- ndc
- 82292-040, 82292-040-01, 82292-040-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en